The UT Gastroenterology / Hepatology research training program is aimed at producing the next generation of scientific leaders focused on understanding digestive and liver diseases. The program involves a variety of disciplines broadly categorized into two main areas: basic scientific research and patient-oriented clinical and translational research. The training program accepts primarily individuals with a background in Internal Medicine (M.D. or M.D./Ph.D. candidates), but also provides opportunities to trainees in Pediatrics, Surgery or Pathology. In addition, trainees without clinical training (Ph.D. candidates) are also part of our program. One unique characteristic is the inclusion of a significant proportion of minority trainees, primarily of Hispanic origin. Trainees benefit from a vast array of potential mentors including 35 Faculty that participate directly in this program, as well as a very rich milieu of scientific investigators across our campus. The scientific base of th training program includes research expertise in multiple areas critically important to the field such as mucosal immunology, microbial-host interactions, and inflammatory bowel disease;intestinal stem cells and malignant transformation in the GI tract, particularly the esophagus and colon;cancer prevention and screening;morphogenesis of the digestive system;obesity, liver steatosis, lipid metabolism and gallstone disease;immune responses in the liver and acute liver failure;hepatic fibrosis and portal hypertension;and, viral hepatitis and anti-viral immunity. Th training curriculum is flexible, but has two basic components. First, all of our trainees participae in a structured lecture series that highlights cutting edge research in fields of gastroenterology and hepatology. Similarly, a course in responsible conduct of research developed by the Graduate School of Biomedical Sciences is a core component of the training experience. In addition to core educational activities, direct training in research takes place primarily under th research mentor's guidance in a basic laboratory or as part of a clinical research group. Typically, our trainees devote 2 to 3 years to their research enterprise. The basic science training experience includes learning a variety of techniques in biochemistry, physiology, molecular biology and genetics, as well as participation in scientific meetings relevant to the particular discipline. On the other hand, clinical and translational research involves formal training in study design, including ethics and biostatics, through a Master's program in Clinical Science offered at our University. Finally, for our trainees with a clinical background in Internal Medicine, this research training program is integrated with our clinical fellowship in Gastroenterology and Hepatology, which includes a minimum of 18 months of dedicated clinical rotations. Therefore, in most instances the training period will last from 4 to 6 years for the fiv individuals for whom support is being requested. Altogether, this program is designed to train individuals who will be effective investigators and academic leaders in the fields of Gastroenterology and Hepatology.

Public Health Relevance

Digestive and liver diseases contribute to 9.8% of all causes of mortality and are the source of substantial healthcare direct costs in the USA, estimated at $97.8 billion in 2004. Thus, this group of disorders represents a major public health problem that requires significant research into disease prevention and treatment. This grant will support a training program aimed at preparing the next generation of scientists focused on digestive and liver disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007745-17
Application #
8474745
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
1997-01-01
Project End
2017-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
17
Fiscal Year
2013
Total Cost
$199,024
Indirect Cost
$18,462
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Zacharias, Tresa; Wang, Winnie; Dao, Doan et al. (2015) HBV Outreach Programs Significantly Increase Knowledge and Vaccination Rates Among Asian Pacific Islanders. J Community Health 40:619-24
McFarlane, Matthew R; Cantoria, Mary Jo; Linden, Albert G et al. (2015) Scap is required for sterol synthesis and crypt growth in intestinal mucosa. J Lipid Res 56:1560-71
Mokadem, Mohamad; Zechner, Juliet F; Uchida, Aki et al. (2015) Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice. PLoS One 10:e0139960
Wang, Tao; Zhan, Xiaowei; Bu, Chun-Hui et al. (2015) Real-time resolution of point mutations that cause phenovariance in mice. Proc Natl Acad Sci U S A 112:E440-9
Phillips-Krawczak, Christine A; Singla, Amika; Starokadomskyy, Petro et al. (2015) COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A. Mol Biol Cell 26:91-103
Li, Haiying; Koo, Yeon; Mao, Xicheng et al. (2015) Endosomal sorting of Notch receptors through COMMD9-dependent pathways modulates Notch signaling. J Cell Biol 211:605-17
Rockey, Don C; Vierling, John M; Mantry, Parvez et al. (2014) Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology 59:1073-83
Zhang, Qiao; Shalaby, Nevine A; Buszczak, Michael (2014) Changes in rRNA transcription influence proliferation and cell fate within a stem cell lineage. Science 343:298-301
Calder, Thomas; de Souza Santos, Marcela; Attah, Victoria et al. (2014) Structural and regulatory mutations in Vibrio parahaemolyticus type III secretion systems display variable effects on virulence. FEMS Microbiol Lett 361:107-14
Li, Haiying; Chan, Lillienne; Bartuzi, Paulina et al. (2014) Copper metabolism domain-containing 1 represses genes that promote inflammation and protects mice from colitis and colitis-associated cancer. Gastroenterology 147:184-195.e3

Showing the most recent 10 out of 62 publications